While uroflowmetry is a useful tool for assessing urinary function, it is not a standalone diagnostic test for Cancer. Its primary role is to detect abnormalities in urine flow that may indicate the presence of an obstruction or dysfunction. Therefore, it is usually combined with other diagnostic tests, such as imaging studies (CT scans, MRIs), cystoscopy, and biopsy, to provide a comprehensive evaluation.
